| | GLA, RPL36A-HNRNPH2 (N419D +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +3 more | |
| | GLA, RPL36A-HNRNPH2 (T412A +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiomyopathy | |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiomyopathy +2 more | |
| | GLA, RPL36A-HNRNPH2 (D313Y +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiomyopathy +6 more | GConflicting classifications of pathogenicity; other |
| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease +4 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (R220Q +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +1 more | |
| | GLA, RPL36A-HNRNPH2 (N215S +1 more) | Single nucleotide variant (missense variant +2 more) | Fabry disease +4 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Cardiomyopathy +4 more | |
| | | Microsatellite (intron variant) | Cardiomyopathy +3 more | |
| | | Single nucleotide variant (intron variant) | Cardiomyopathy | |
| | GLA, RPL36A-HNRNPH2 (P205T +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +3 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (S201A +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +2 more | |
| | GLA, RPL36A-HNRNPH2 (W162* +1 more) | Single nucleotide variant (nonsense +2 more) | Cardiomyopathy +1 more | GPathogenic/Likely pathogenic |
| | GLA, RPL36A-HNRNPH2 (A143T +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +5 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (S126G +1 more) | Single nucleotide variant (missense variant +2 more) | Cardiovascular phenotype +4 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (R118C +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +4 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (Q99fs +1 more) | Deletion (frameshift variant +2 more) | Fabry disease +2 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (synonymous variant +2 more) | Fabry disease +4 more | GConflicting classifications of pathogenicity |
| | GLA, RPL36A-HNRNPH2 (W24R) | Single nucleotide variant (missense variant +2 more) | Fabry disease +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | Cardiomyopathy +2 more | |
| | | Single nucleotide variant (missense variant +2 more) | not specified +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +2 more) | not specified +2 more | GConflicting classifications of pathogenicity |